Withdrawal Syndrome After Stopping Opioids Is Not Evidence of Drug Dependence, WHO Committee Says

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 5 No 10
Volume 5
Issue 10

VANCOUVER, BC-Drug dependence is not physical dependence alone, nor is it the same as drug tolerance. "Drug dependence is primarily psychological dependence, or compulsive use of drugs for their mood-altering effects and continued use despite harm," David E. Joranson, MSSW, said at the WHO workshop on cancer pain.

VANCOUVER, BC-Drug dependence is not physical dependence alone,nor is it the same as drug tolerance. "Drug dependence isprimarily psychological dependence, or compulsive use of drugsfor their mood-altering effects and continued use despite harm,"David E. Joranson, MSSW, said at the WHO workshop on cancer pain.

The WHO Expert Committee on Drug Dependence recently clarifiedthat a cancer patient who has been receiving opioids for painand who stops the drug would go through a withdrawal syndromeas evidence of physical dependence, but that individual is notconsidered to be drug dependent.

"Physical dependence by itself is no longer sufficient todefine drug dependence or addiction," Mr. Joranson said."It is important for us to teach this and to clear up themythology about the relationship between opioid analgesia andaddiction."

Related Videos
Adrienne Bruce Shannon, MD, discussed ways to improve treatment and surgical outcomes for patients with dMMR gastroesophageal cancer.
Barbara Smith, MD, PhD, spoke about the potential use of pegulicianine-guided breast cancer surgery based on reports from the phase 3 INSITE trial.
Patient-reported symptoms following surgery appear to improve with the use of perioperative telemonitoring, says Kelly M. Mahuron, MD.
Treatment options in the refractory setting must improve for patients with resected colorectal cancer peritoneal metastasis, says Muhammad Talha Waheed, MD.
Karine Tawagi, MD, and Sia Daneshmand, MD, with the Oncology Brothers presenting slides
Karine Tawagi, MD, and Sia Daneshmand, MD, with the Oncology Brothers presenting slides
Related Content